| Product Code: ETC13261158 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Infectious Testing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Infectious Testing Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Infectious Testing Market Revenues & Volume, 2021 & 2031F |
3.3 North America Infectious Testing Market - Industry Life Cycle |
3.4 North America Infectious Testing Market - Porter's Five Forces |
3.5 North America Infectious Testing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Infectious Testing Market Revenues & Volume Share, By Product and Service, 2021 & 2031F |
3.7 North America Infectious Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 North America Infectious Testing Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.9 North America Infectious Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 North America Infectious Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Infectious Testing Market Trends |
6 North America Infectious Testing Market, 2021 - 2031 |
6.1 North America Infectious Testing Market, Revenues & Volume, By Product and Service, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Infectious Testing Market, Revenues & Volume, By Assays, 2021 - 2031 |
6.1.3 North America Infectious Testing Market, Revenues & Volume, By Kits and Reagents, 2021 - 2031 |
6.1.4 North America Infectious Testing Market, Revenues & Volume, By Instruments, 2021 - 2031 |
6.1.5 North America Infectious Testing Market, Revenues & Volume, By Services and Software, 2021 - 2031 |
6.2 North America Infectious Testing Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Infectious Testing Market, Revenues & Volume, By Immunodiagnostics, 2021 - 2031 |
6.2.3 North America Infectious Testing Market, Revenues & Volume, By Clinical Microbiology, 2021 - 2031 |
6.2.4 North America Infectious Testing Market, Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021 - 2031 |
6.2.5 North America Infectious Testing Market, Revenues & Volume, By Isothermal Nucleic Acid Amplification Technology (INAAT), 2021 - 2031 |
6.2.6 North America Infectious Testing Market, Revenues & Volume, By DNA Sequencing and Next-Generation Sequencing (NGS), 2021 - 2031 |
6.2.7 North America Infectious Testing Market, Revenues & Volume, By DNA Microarray, 2021 - 2031 |
6.2.8 North America Infectious Testing Market, Revenues & Volume, By Other Technologies, 2021 - 2031 |
6.3 North America Infectious Testing Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Infectious Testing Market, Revenues & Volume, By Hepatitis, 2021 - 2031 |
6.3.3 North America Infectious Testing Market, Revenues & Volume, By Human Immunodeficiency Virus (HIV), 2021 - 2031 |
6.3.4 North America Infectious Testing Market, Revenues & Volume, By Chlamydia Trachomatis Genital Infection and Gonorrhoea (CT/NG), 2021 - 2031 |
6.3.5 North America Infectious Testing Market, Revenues & Volume, By Hospital-Acquired Infections (HAIS), 2021 - 2031 |
6.3.6 North America Infectious Testing Market, Revenues & Volume, By Human Papillomavirus (HPV), 2021 - 2031 |
6.3.7 North America Infectious Testing Market, Revenues & Volume, By Tuberculosis (TB), 2021 - 2031 |
6.3.8 North America Infectious Testing Market, Revenues & Volume, By Influenza, 2021 - 2031 |
6.3.9 North America Infectious Testing Market, Revenues & Volume, By Other Infectious Disease, 2021 - 2031 |
6.4 North America Infectious Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.2 North America Infectious Testing Market, Revenues & Volume, By Hospital/ Clinical Laboratories, 2021 - 2031 |
6.4.3 North America Infectious Testing Market, Revenues & Volume, By Reference Laboratories, 2021 - 2031 |
6.4.4 North America Infectious Testing Market, Revenues & Volume, By Physician Offices, 2021 - 2031 |
6.4.5 North America Infectious Testing Market, Revenues & Volume, By Academic/ Research Institutes, 2021 - 2031 |
6.4.6 North America Infectious Testing Market, Revenues & Volume, By Other, 2021 - 2031 |
7 North America Infectious Testing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Infectious Testing Market, Revenues & Volume, By Product and Service, 2021 - 2031 |
7.2.1 United States (US) Infectious Testing Market, Revenues & Volume, By Product and Service, 2021 - 2031 |
7.2.2 Canada Infectious Testing Market, Revenues & Volume, By Product and Service, 2021 - 2031 |
7.2.3 Rest of North America Infectious Testing Market, Revenues & Volume, By Product and Service, 2021 - 2031 |
7.3 North America Infectious Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
7.3.1 United States (US) Infectious Testing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.2 Canada Infectious Testing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.3 Rest of North America Infectious Testing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4 North America Infectious Testing Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.4.1 United States (US) Infectious Testing Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.4.2 Canada Infectious Testing Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.4.3 Rest of North America Infectious Testing Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.5 North America Infectious Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United States (US) Infectious Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Canada Infectious Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 Rest of North America Infectious Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
8 North America Infectious Testing Market Key Performance Indicators |
9 North America Infectious Testing Market - Export/Import By Countries Assessment |
10 North America Infectious Testing Market - Opportunity Assessment |
10.1 North America Infectious Testing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Infectious Testing Market Opportunity Assessment, By Product and Service, 2021 & 2031F |
10.3 North America Infectious Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.4 North America Infectious Testing Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
10.5 North America Infectious Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
11 North America Infectious Testing Market - Competitive Landscape |
11.1 North America Infectious Testing Market Revenue Share, By Companies, 2022 |
11.2 North America Infectious Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here